Adnexus Biotechnologies Inc. is at the forefront of the battle against malaria by developing Trapicolast, an antimalarial medication created through the innovative Sutra™ AI platform. This advancement exemplifies the transformative potential of artificial intelligence in revolutionizing the drug discovery process.